An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 112 (1) , 184-198
- https://doi.org/10.1016/j.pharmthera.2006.04.006
Abstract
No abstract availableKeywords
Funding Information
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 138 references indexed in Scilit:
- Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivoClinical Pharmacology & Therapeutics, 2005
- Efficacy and Safety Outcomes Among De Novo Renal Transplant Recipients Managed by C2 Monitoring of Cyclosporine A Microemulsion: Results of a 12-Month, Randomized, Multicenter StudyTransplantation, 2005
- An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in SingaporeDrug Metabolism Reviews, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Is acute rejection deleterious to long-term allograft function?Journal of Hepatology, 1998
- Racial variation in dosage requirements of tacrolimusThe Lancet, 1996
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- Progress Report of an External Quality Assessment Scheme for Cyclosporine AssayTherapeutic Drug Monitoring, 1996
- GENERAL GUIDELINES FOR THE USE OF TACROLIMUS IN ADULT LIVER TRANSPLANT PATIENTSTransplantation, 1996
- Intestinal Transplantation in Composite Visceral Grafts or AloneAnnals of Surgery, 1992